- Home
- MCHX vs VERU Comparison
MCHX vs VERU Comparison
Compare MCHX & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCHX
- VERU
- Stock Information
- Founded
- MCHX 2003
- VERU 1971
- Country
- MCHX United States
- VERU United States
- Employees
- MCHX N/A
- VERU N/A
- Industry
- MCHX Business Services
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- MCHX Consumer Discretionary
- VERU Health Care
- Exchange
- MCHX Nasdaq
- VERU Nasdaq
- Market Cap
- MCHX 84.3M
- VERU 76.9M
- IPO Year
- MCHX 2004
- VERU 1990
- Fundamental
- Price
- MCHX $1.44
- VERU $0.55
- Analyst Decision
- MCHX
- VERU Strong Buy
- Analyst Count
- MCHX 0
- VERU 3
- Target Price
- MCHX N/A
- VERU $4.33
- AVG Volume (30 Days)
- MCHX 31.9K
- VERU 2.1M
- Earning Date
- MCHX 05-06-2025
- VERU 05-07-2025
- Dividend Yield
- MCHX N/A
- VERU N/A
- EPS Growth
- MCHX N/A
- VERU N/A
- EPS
- MCHX N/A
- VERU N/A
- Revenue
- MCHX $48,122,000.00
- VERU $16,886,419.00
- Revenue This Year
- MCHX $4.71
- VERU N/A
- Revenue Next Year
- MCHX N/A
- VERU N/A
- P/E Ratio
- MCHX N/A
- VERU N/A
- Revenue Growth
- MCHX N/A
- VERU 22.46
- 52 Week Low
- MCHX $1.20
- VERU $0.45
- 52 Week High
- MCHX $2.40
- VERU $1.75
- Technical
- Relative Strength Index (RSI)
- MCHX 39.02
- VERU 51.53
- Support Level
- MCHX $1.29
- VERU $0.51
- Resistance Level
- MCHX $1.55
- VERU $0.58
- Average True Range (ATR)
- MCHX 0.11
- VERU 0.05
- MACD
- MCHX 0.02
- VERU -0.00
- Stochastic Oscillator
- MCHX 51.72
- VERU 40.92
About MCHX Marchex Inc. Class B
Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.